These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9739096)

  • 1. HIV gp120: double lock strategy foils host defences.
    Sattentau QJ
    Structure; 1998 Aug; 6(8):945-9. PubMed ID: 9739096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular architecture of native HIV-1 gp120 trimers.
    Liu J; Bartesaghi A; Borgnia MJ; Sapiro G; Subramaniam S
    Nature; 2008 Sep; 455(7209):109-13. PubMed ID: 18668044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.
    Diskin R; Marcovecchio PM; Bjorkman PJ
    Nat Struct Mol Biol; 2010 May; 17(5):608-13. PubMed ID: 20357769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.
    Kwong PD; Wyatt R; Majeed S; Robinson J; Sweet RW; Sodroski J; Hendrickson WA
    Structure; 2000 Dec; 8(12):1329-39. PubMed ID: 11188697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the principal neutralization site of HIV-1.
    Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
    Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conformational switch is associated with receptor affinity in peptides derived from the CD4-binding domain of gp120 from HIV I.
    Reed J; Kinzel V
    Biochemistry; 1991 May; 30(18):4521-8. PubMed ID: 2021643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of an HIV-2 gp120 in Complex with CD4.
    Davenport YW; West AP; Bjorkman PJ
    J Virol; 2016 Feb; 90(4):2112-8. PubMed ID: 26608312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
    Raja A; Venturi M; Kwong P; Sodroski J
    J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CD4 Binding on Conformational Dynamics, Molecular Motions, and Thermodynamics of HIV-1 gp120.
    Li Y; Deng L; Yang LQ; Sang P; Liu SQ
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of peptide libraries as potential anti-HIV compounds, via inhibition of gp120/cell membrane interactions, using the gp120/cd4/fab17 crystal structure.
    Boussard C; Doyle VE; Mahmood N; Klimkait T; Pritchard M; Gilbert IH
    Eur J Med Chem; 2002 Nov; 37(11):883-90. PubMed ID: 12446047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
    Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
    Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-induced epitopes in the HIV envelope glycoprotein, gp120.
    DeVico AL
    Curr HIV Res; 2007 Nov; 5(6):561-71. PubMed ID: 18045112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD; Doyle ML; Casper DJ; Cicala C; Leavitt SA; Majeed S; Steenbeke TD; Venturi M; Chaiken I; Fung M; Katinger H; Parren PW; Robinson J; Van Ryk D; Wang L; Burton DR; Freire E; Wyatt R; Sodroski J; Hendrickson WA; Arthos J
    Nature; 2002 Dec; 420(6916):678-82. PubMed ID: 12478295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.